Cargando…
Advances in the Current Understanding of the Mechanisms Governing the Acquisition of Castration-Resistant Prostate Cancer
SIMPLE SUMMARY: Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer with a low survival rate, as the CRPC patients only survive for 9–13 months on average. In this narrative review, we first outline the most common androgen receptor (AR) receptor-related mechanisms, hi...
Autores principales: | Mao, Yifeng, Yang, Gaowei, Li, Yingbang, Liang, Guowu, Xu, Wangwang, Hu, Mingqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367587/ https://www.ncbi.nlm.nih.gov/pubmed/35954408 http://dx.doi.org/10.3390/cancers14153744 |
Ejemplares similares
-
Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis
por: Hu, Mingqiu, et al.
Publicado: (2023) -
Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis
por: Mao, Yifeng, et al.
Publicado: (2022) -
Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer
por: Hu, Mingqiu, et al.
Publicado: (2021) -
Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments
por: Le, Thi Khanh, et al.
Publicado: (2023) -
Current Treatment Strategies for Castration-Resistant Prostate Cancer
por: Kim, Se Joong, et al.
Publicado: (2011)